MY143583A - Tetrahydroindolone and tetrahydroindazolone derivatives - Google Patents

Tetrahydroindolone and tetrahydroindazolone derivatives

Info

Publication number
MY143583A
MY143583A MYPI20071433A MYPI20071433A MY143583A MY 143583 A MY143583 A MY 143583A MY PI20071433 A MYPI20071433 A MY PI20071433A MY PI20071433 A MYPI20071433 A MY PI20071433A MY 143583 A MY143583 A MY 143583A
Authority
MY
Malaysia
Prior art keywords
compounds
tetrahydroindolone
formula
disclosed
tetrahydroindazolone
Prior art date
Application number
MYPI20071433A
Inventor
Kenneth He Huang
Jeron Eaves
James Veal
Thomas E Barta
Lifeng Geng
Lindsay Hinkley
Gunnar J Hanson
Original Assignee
Serenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serenex Inc filed Critical Serenex Inc
Priority to MYPI20071433A priority Critical patent/MY143583A/en
Publication of MY143583A publication Critical patent/MY143583A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DISCLOSED ARE COMPOUNDS AND PHARMACEUTICALLY ACCEPTABLE SALTS OF FORMULA I WHEREIN R1, R2, R3, R4, R5, R6, R7, N, Q1, Q2, Q3, Y, AND X1- X4 ARE AS DEFINED HEREIN. COMPOUNDS OF FORMULA I ARE USEFUL IN THE TREATMENT OF DISEASES AND/OR CONDITIONS RELATED TO CELL PROLIFERATION, SUCH AS CANCER, INFLAMMATION, ARTHRITIS, ANGIOGENESIS, OR THE LIKE. ALSO DISCLOSED ARE PHARMACEUTICAL COMPOSITIONS COMPRISING COMPOUNDS OF THE INVENTION AND METHODS OF TREATING THE AFOREMENTIONED CONDITIONS USING SUCH COMPOUNDS.
MYPI20071433A 2007-08-24 2007-08-24 Tetrahydroindolone and tetrahydroindazolone derivatives MY143583A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20071433A MY143583A (en) 2007-08-24 2007-08-24 Tetrahydroindolone and tetrahydroindazolone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20071433A MY143583A (en) 2007-08-24 2007-08-24 Tetrahydroindolone and tetrahydroindazolone derivatives

Publications (1)

Publication Number Publication Date
MY143583A true MY143583A (en) 2011-05-31

Family

ID=45020825

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20071433A MY143583A (en) 2007-08-24 2007-08-24 Tetrahydroindolone and tetrahydroindazolone derivatives

Country Status (1)

Country Link
MY (1) MY143583A (en)

Similar Documents

Publication Publication Date Title
UA92907C2 (en) Tetrahydroindazolone derivatives
WO2008024978A3 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
WO2007035620A3 (en) Carbazole derivatives
SG149033A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
MX2014012695A (en) Isoindolone derivatives.
WO2008024980A3 (en) Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
WO2008024977A3 (en) Isoquinoline, quinazoline and phthalazine derivatives
MX2009003157A (en) Therapeutic pyrazolyl thienopyridines.
NZ577916A (en) Cyclopamine analogs
MY158106A (en) Inhibitors of e1 activating enzymes
MX2010002353A (en) Heterocyclic amides useful for the treatment of cancer and psoriasis.
PL1891029T3 (en) Organic compounds for the treatment of imflammatory or alleric conditions
MX2009006704A (en) New compounds.
MY167135A (en) Fused heterocyclic derivatives and methods of use
MX2009006706A (en) Bicyclic heterocyclic compounds as fgfr inhibitors.
UA100007C2 (en) Heterocyclic inhibitors of mek, use thereof and pharmaceutical composition containing thereof
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX2015012431A (en) Pyrrole amide inhibitors.
NO20090434L (en) Heteroberl compounds useful as inhibitors of E1-activating enzymes
MX2011009796A (en) Inhibitors of pi3 kinase.
MX2010007683A (en) Fused heterocyclic derivatives and methods of use.
GEP20125624B (en) Pyridazine derivatives as smo inhibitors
MX2009006543A (en) Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer.
TW200806300A (en) New therapeutic combinations for the treatment of depression
IN2012DN03182A (en)